Biosynthesis of bicyclic depsipeptide histone deacetylase inhibitors (#46)
Xinyun Jian
1
2
3
4
,
Jinlian Zhao
1
,
Edward Marschall
2
3
,
Emmanuel L.C. de Los Santos
1
4
,
Douglas M. Roberts
1
4
,
Lona Alkhalaf
1
4
,
Max J. Cryle
2
3
,
Greg L. Challis
1
2
3
4
- Chemistry Department, University of Warwick, Coventry, United Kingdom
- Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
- ARC Centre of Excellence for Innovations in Peptide and Protein Science, Monash University, Clayton, Victoria, Australia
- Warwick Integrative Synthetic Biology Centre, University of Warwick, Coventry, United Kingdom
Publish consent withheld
- Shigematsu, N. et al. FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum no. 968. II. Structure determination. J. Antibiot. (Tokyo). 47, 311–314 (1994).
- Masuoka, Y. et al. Spiruchostatins A and B, novel gene expression-enhancing substances produced by Pseudomonas sp. Tetrahedron Lett. 42, 41–44 (2001).
- Biggins, J. B. et al. Acyldepsipeptide HDAC inhibitor production induced in Burkholderia thailandensis. Org. Lett. 13, 1536–9 (2011).
- Masakuni O. et al. 1991. JP 3141296.
- Cheng, Y.-Q. et al. Characterization of a gene cluster responsible for the biosynthesis of anticancer agent FK228 in Chromobacterium violaceum No. 968. Appl. Environ. Microbiol. 73, 3460–9 (2007).
- Potharla, V. Y. et al. Identification and characterization of the spiruchostatin biosynthetic gene cluster enable yield improvement by overexpressing a transcriptional activator. J. Ind. Microbiol. Biotechnol. 41, 1457–1465 (2014).